SavedAdd your journal

Journals / Medical Network Klinik Bilimler ve Doktor / 2002 / Cilt: 8 - Sayı: 3

Our carcinoid tumor cases with different clinical presentations

Farklı klinik seyirli karsinoid tümör olgularımız

Öz F. Füsun BÖLÜKBAŞ
Cengiz BÖLÜKBAŞ
Necmi KURT
Nilgün AKBULUT
Taflan SALEPÇİ
Rahmi IRMAK
Pages
290–299
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, 4 carcinoid tumor cases with different clinical presentations are presented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Carcinoid tumors arise from neuroendocrine cells throughout the body, but are the most common in the gastrointestinal tract, pancreas and pulmonary bronchi.
📊
Key Findings & Data:The incidence of carcinoid tumors in the United States is approximately 1/15 million each year.
💡
Conclusion & Impact:In this article, 4 carcinoid tumor cases with different clinical presentations are presented.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Tanı teknik ve işlemleri · Erişkin · Karsinoid tümör

Abstract

Carcinoid tumors arise from neuroendocrine cells throughout the body, but are the most common in the gastrointestinal tract, pancreas and pulmonary bronchi. Ninety percent of these tumors arise in the enterochromaffin cells within the gastrointestinal tract. The incidence of carcinoid tumors in the United States is approximately 1/15 million each year. In this article, 4 carcinoid tumor cases with different clinical presentations are presented.

Özet

Karsinoid tümörler nöroendokrin hücrelerden gelişip, en sık gastrointestinal sistem(GIS), pankreas ve pulmoner bronşlarda bulunur.Bu tümörlerin %90'ı, GIS deki enterokromafin hücrelerden köken alır. Amerika Birleşik Devletlerinde insidans, yılda 15 milyonda birdir. Bu yazımızda farklı klinik seyirli 4 karsinoid tümör olgusu sunulmuştur.

🔖

Cite This Article

BÖLÜKBAŞ, Ö. F. F., BÖLÜKBAŞ, C., KURT, N., AKBULUT, N., SALEPÇİ, T., IRMAK, R. (2002). Our carcinoid tumor cases with different clinical presentations. Medical Network Klinik Bilimler ve Doktor, Cilt: 8 - Sayı: 3, 290–299. https://ajindex.com/articles/279189

References (1)

  1. Kvols LK.Gastointestinal Carcinoid Tumors and Malignant Carcinoid Syndrome.In:Feldman M,Scharschmidt BF,Sleisenger MH.eds.Sleisenger & Fordtran's Gastrointestinal and Liver Disease. Philadelphia:W.B. Saunders Company, 1998:1831-43. Williams ED.Sandler M.The classification of carcinoid tumors.Lancet 1963; 5:238-9. Kaplan LM.Endocrin tumors of the gastrointestinal tract and pancreas. In: Isselbacher KJ.Braunvald E,Wilson JD,Martin JB,Fauci AS.Kasper DL.eds.Harrison's Principles of Internal Medicine.New York: McGraw Hill, 1994:1535-42. Fornero G.Rosato B.Luc R,Coluccio G.Carcinoid of the cecal appendix.Minerva Chir. 1997; 52:1223-6. Feldman JM,O'Dorisio TM.Role öf neuropeptides and serotonin in the diagnosis of carcinoid tumors. Am J Med 1986; 81:41-8. Davis Z.Moertel C.G.and Me Ilrath D.C.The malignant carcinoid syndrom. Surg Gynecol Obstet.1973; 137:628. McDermott EWM.Guduric B.Brennan MF,et al.Prognostic variables in patients with gastrointestinal carcinoid tumors.Br J Surg 1994; 81:1007-9. Gorden P.Comi RL,Maton PN,et al.Somatostatin and somatostatin analogue (SMS201-995) in treatment of hormone secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut.Ann Int Med 1989; 110:35-50. Eriksson JM,Arnberg H,Öberg K,et al.A polyclonal antiserum against chromogranin A and B-a new sensitive marker for neuroendocrin tumors.Acta Endocrinol 1990; 122:145-55. Shebani KO,Souba WW,Finkelstein DM et al.Prognosis and survival in patients with gastrointestinal tract carcinoid tumors.Ann Surg 1999; 229:815-21. Tarkun P.Üstün H,Özgür O.Gastrointestinal karsinoid tümörlerde yeni görüşler.Endoskopi2001; 12:31-6. Janson ET.Holmberg L,Stridsberg M,et al.Carcinoid tumors:Analysis of prognostic factors and survival in 301 patients from a refferal center.Ann Oncol 1997; 8:685-90. Godwin JD.Carcinoid tumors.An analysis of 2837 cases.Cancer 1975; 36:560-9. Engstrom,P.F,Lavin P.T.Moertel C.G et al.Streptozotocin plus fluouracil versus doxorubicin therapy for metastatic carcinoid tumor.J Clin Oncol. 1984; 2:1255. Moertel C.G,Engstrom P.F and Shutt A.J.Tamoxifen therapy for metastatic carcinoid tumor.Ann Intern Med. 1984; 100:531. Oberg K.Norheim I,Lind E et al.Treatment of malignant carcinoid tumors with human leukocyte interferon.Cancer Treat Rep 1986; 70:1297. Moertel C.G,Rubin J.and Kvols L.K.Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leucocyte A interferon.J Clin Oncol 1989; 7:865. Moertel C